SARA ARRINGTON: Open Payments
NPI 1093960668 · WEST POINT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 20 payments from 11 companies in 2025. Trend: 2023 $397 · 2024 $307 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $108 |
| ABBVIE INC. | 4 | $76 |
| Lilly USA, LLC | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Organon LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
| Averitas Pharma Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Ozempic, QULIPTA, MOUNJARO, VOQUEZNA, PURIFIED CORTROPHIN GEL, Rybelsus, UBRELVY, VRAYLAR.
Industry payments across UT — which companies pay providers there.
